Newborn Lung Treatment Poses Risk of Intestinal Perforation
A treatment commonly prescribed to reduce the risk of chronic lung disease in extremely premature infants does not reduce the risk of death or chronic lung disease in these infants and may increase the risk for perforation of the intestines, according to a study by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network.